Calculating the Costs of Clinical Trials
Patients eager to contribute to research may not be fully aware of the hidden costs of trial participation
Of the three potential risks of participating...
Pediatric Hematology/Oncology: A Small Specialty Experiencing Big Changes
When Mona D. Shah, MD, MBA, finished her medical training in pediatric hematology/oncology in 2007, she estimated that most of her fellow trainees went...
Mainstreaming Alternative and Complementary Medicine
While some treatments for hematologic conditions such as sickle cell disease (SCD) and cancer, have been refined over time – increasing survival rates and...
Staging the Aging
Routine assessment of frailty can help clinicians tailor treatments and supportive care to an individual patient’s needs
Hematologic malignancies are often diseases of older adults...
The Other Opioid Epidemic
Federal crackdowns on opioid prescribing have shifted the crisis from overdoses to undertreatment
The United States is in the grip of an opioid epidemic that...
Breakthroughs for Bleeding: Updates in Treating and Managing Hemophilia
In 1982, the gene encoding factor IX (FIX) was cloned, followed by the cloning of the factor VIII (FVIII) gene in 1984. The events...
What Does the Future Hold for Gene Therapy in Nonmalignant Hematology?
The human genome contains about 25,000 genes that encode myriad proteins that drive the processes necessary for life. But disruptions, deletions, and mutations can...
Taking the Pulse of Health Care and Politics
With more health-related topics becoming politicized, it may be hard to keep politics out of the exam room.
As another U.S. presidential election approaches, Americans...
The Spy Next Door?
Academic institutions and government organizations strive to prevent research espionage while maintaining open scientific collaborations
For decades, the U.S. has fostered international research collaborations with...
In Myeloma, New Drugs, Skyrocketing Price Tags
In late February, seven pharmaceutical executives were called before the U.S. Senate Finance Committee to testify about the prices of brand-name prescription drugs, which...
Current Issue
December 2019, Volume 5, Issue 15
This issue examines the hidden costs of participating in clinical trials, explores the pediatric hematology/oncology workforce, and more.
